CCT3 and hepatocellular carcinoma: CCT3 knockdown increases the sensitivity of HCC cells to chemotherapeutic drugs such as the microtubule‐destabilising drug vincristine while reducing their sensitivity to the microtubule‐stabilising drug paclitaxel.119